Biotech News

LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial

Lixte Biotechnology Holdings (LIXT)Lixte Biotechnology Holdings2026-06-25 13:46 ESTClinical readout

LIXT (LIXT) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is lixt.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

LIXTLixte Biotechnology Holdings2026-06-25 13:46 EST

LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29

View all latest news

Lixte Biotechnology Holdings

Lixte Biotechnology Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Recent company news

LIXTLixte Biotechnology Holdings2026-06-26 09:29 EST

LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026

LIXTLixte Biotechnology Holdings2026-06-26 09:29 EST

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

LIXTLixte Biotechnology Holdings2026-06-26 09:29 EST

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

LIXTLixte Biotechnology Holdings2026-06-26 09:29 EST

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

LIXTLixte Biotechnology Holdings2026-06-26 09:29 EST

LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States